Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Biliary Atresia Study in Infants and Children
for
Biliary Atresia
Location: Philadelphia PA, Atlanta GA, Cincinnati OH, Chicago IL,
Sponsor: Arbor Research Collaborative for Health
Sex: All
Age: 0 - 20
Code: NCT00345553
Recruiting
CRS Questionnaire Validation Project
for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: Boston MA, Philadelphia PA, Virginia City VA, Toronto,
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases
Sex: All
Age: 18+
Code: NCT06970977
Recruiting
Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
for
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Location: Pittsburgh PA
Sponsor: Jerry Vockley, MD, PhD
Sex: All
Age: 4+
Code: NCT06773026
Phase 2, Recruiting
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
for
Mobility Limitation
Location: Hershey PA, Pittsburgh PA
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 65+
Code: NCT06396247
Phase 2, Phase 3, Recruiting
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Location: Philadelphia PA, Miami FL, Madison WI, Dallas TX,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 18+
Code: NCT06789445
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase 2, Recruiting
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Westwood NJ, Chapel Hill NC, Miami FL, Sweetwater FL,
Sponsor: Piomic Medical
Sex: All
Age: 22 - 70+
Code: NCT05758545
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, Shirley NY, New Haven CT, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06324357
Phase 1, Phase 2, Recruiting
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
for
Hematopoietic Stem Cell Transplant (HSCT),
Location: Boston MA, Philadelphia PA, Cincinnati OH,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0 - 24
Code: NCT04098445
Recruiting
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Location: Boston MA, Fairfax VA, Pittsburgh PA, Dallas TX
Sponsor: ImmVira Pharma Co. Ltd
Sex: All
Age: 18+
Code: NCT04370587
Phase 1, Phase 2, Recruiting
Monitored Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia
for
Intermittent Exotropia
Location: Elkins Park PA
Sponsor: Salus University
Sex: All
Age: 3 - 11
Code: NCT02902887
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Scarborough ME, Boston MA, Providence RI, Burlington MA,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase 3, Recruiting
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
for
Hemophilia B
Location: Pittsburgh PA, Hamilton, Ann Arbor MI, Houston TX,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT06003387
Phase 3, Recruiting
Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
for
Ileal Pouch
Location: New York NY, Hershey PA, Chapel Hill NC,
Sponsor: Exegi Pharma, LLC
Sex: All
Age: 18+
Code: NCT05938465
Phase 1, Phase 2, Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults
for
Invasive Candidiasis
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0+
Code: NCT05763251
Recruiting
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT05750498
Recruiting
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Boston MA, The Bronx NY, Washington D.C. DC, Miami FL,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 18
Code: NCT05550298
Recruiting
Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
for
Cataract
Location: Poughkeepsie NY, Kingston PA, Panama City FL,
Sponsor: Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons
Sex: All
Age: 22+
Code: NCT05186298
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: New York NY, Montreal, Terrebonne, Detroit MI,